Eurofins Will Be Included in the CAC 40 Index From September 17
LUXEMBOURG--(BUSINESS WIRE)--Sep 10, 2021--
Eurofins Scientific, a global leader in food, environment, pharmaceutical and cosmetic product testing, is very pleased to announce that the Steering Committee of the Euronext Indices has made the decision on 9 September 2021 to include Eurofins Scientific in the CAC 40 Index.
At 9 September 2021, the Group’s market capitalisation stood at more than €23.5 billion. Based on 9 September 2021 share prices this would put Eurofins in the 29 th position in the CAC 40 index ranked by market capitalisation. Eurofins Scientific’s inclusion in the CAC 40 Index will be effective on Friday 17 September 2021, after market close.
Eurofins joins the CAC 40 Index, consisting of large and very large groups, many of which are over 100 years old (on average around 102 years old), only 34 years after its creation in 1987.
Eurofins’ Founder and CEO, Gilles Martin commented: “We are delighted by the decision to include Eurofins in the CAC 40. It is a significant milestone in the history of the group. Since the foundation of its first company in 1987 in Nantes, France with four employees and listing in Paris in 1997, Eurofins Scientific has been one of the fastest growing, listed European groups increasing revenues by 32% (in compound average) since 1988 through organic growth and acquisitions and its share price by more than 30% each year (in compound average) since its IPO in October 1997.
Today Eurofins is a global leader in many of its markets and continues its mission to contribute to a safer and healthier world by providing our customers with innovative and high quality laboratory, research and advisory services, whilst creating opportunities for our employees and generating sustainable shareholder value. This mission has never been more critical than today, where the Group has been agile and innovative, rapidly developing new testing solutions to fight the spread of COVID-19 and its variants.
I would like to take this opportunity to once again thank all of our 55,000 employees and leaders worldwide, whose dedication, innovation and entrepreneurial spirit and focus on service to our customers have been and remain instrumental for the continued success of the group, as well as the clients, suppliers and public and private partners of all Eurofins’ companies around the world for their trust and continued support.”
Eurofins Scientific’s shares are also part of the following indices on Euronext Paris: EURONEXT 100, SBF 120, SBF TOP 80 EW, CAC ALL SHARES, CAC ALL-TRADABLE, CAC HEALTH CARE, CAC L60 RI SW, CAC LARGE 60, CAC LARGE 60 EW, and EN H C EQ & SER EW; on Euronext Amsterdam: EN CORE E100 EW, EN EUR N100 EW, EN EUROZONE 150 EW, EN EUROPE 500, EN EUROZONE 300, and EN EZ L&M 60 EW ; and also MSCI Europe, STOXX Europe 600, and S&P Europe 350.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210909006206/en/
CONTACT: Investor Relations
Eurofins Scientific SE
KEYWORD: LUXEMBOURG EUROPE
INDUSTRY KEYWORD: RESEARCH CLINICAL TRIALS BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL GENERAL HEALTH OTHER SCIENCE SCIENCE
Copyright Business Wire 2021.
PUB: 09/10/2021 01:15 AM/DISC: 09/10/2021 01:16 AM